To evaluate the efficacy, safety, and tolerability for adjunctive treatment of MDD.

  • male or female 18-65 years of age
  • experiencing symptoms of depression for at least 4 weeks
  • * Required Field

    Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.

  • This field is for validation purposes and should be left unchanged.